A. Aparna

Anti-leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX-2, inhibition of BCR/ABL kinase and NF-κB inactivation

T. Chandramohan Reddy, D. Bharat Reddy, A. Aparna et al. · Toxicology in Vitro · 2012 · 79 citations

Inflammation, Bcr/abl Kinase, Hematological Malignancy +11

Imatinib-resistant K562 cells are more sensitive to celecoxib, a selective COX-2 inhibitor: Role of COX-2 and MDR-1

Kalle M. Arunasree, Karnati R. Roy, Kotha Anilkumar et al. · Leukemia Research · 2008 · 65 citations

Tumor Biology, Imatinib-resistant K562 Cells, Selective Cox-2 Inhibitor +7

Lipoxygenase (LOX) Pathway: A Promising Target to Combat Cancer

P. Vishnupriya, A. Aparna · Current Pharmaceutical Design · 2021 · 37 citations

Combat Cancer, Oxysterol, Oncogenic Agent +11

Effects of (15<i>S</i>)‐hydroperoxyeicosatetraenoic acid and (15<i>S</i>)‐hydroxyeicosatetraenoic acid on the acute‐ lymphoblastic‐leukaemia cell line Jurkat: activation of the Fas‐mediated death pathway

Kotha Anil Kumar, Kalle M. Arunasree, Karnati R. Roy et al. · Biotechnology and Applied Biochemistry · 2009 · 19 citations